ExodusPoint Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.1M Buy
+19,985
New +$8.1M 0.07% 260
2024
Q2
Sell
-15,409
Closed -$8.96M 1839
2024
Q1
$8.96M Sell
15,409
-22,547
-59% -$13.1M 0.07% 188
2023
Q4
$20.1M Sell
37,956
-7,995
-17% -$4.24M 0.13% 77
2023
Q3
$23.3M Buy
45,951
+18,350
+66% +$9.29M 0.22% 65
2023
Q2
$14.4M Buy
27,601
+13,337
+94% +$6.96M 0.12% 145
2023
Q1
$8.22M Buy
+14,264
New +$8.22M 0.07% 269
2022
Q3
Sell
-13,548
Closed -$7.36M 2251
2022
Q2
$7.36M Buy
13,548
+972
+8% +$528K 0.09% 260
2022
Q1
$7.43M Sell
12,576
-15,031
-54% -$8.88M 0.09% 241
2021
Q4
$18.4M Buy
27,607
+17,491
+173% +$11.7M 0.19% 77
2021
Q3
$5.78M Sell
10,116
-14,866
-60% -$8.49M 0.08% 316
2021
Q2
$12.6M Sell
24,982
-7,625
-23% -$3.85M 0.14% 84
2021
Q1
$14.9M Buy
32,607
+8,947
+38% +$4.08M 0.22% 65
2020
Q4
$11M Buy
23,660
+17,111
+261% +$7.97M 0.11% 88
2020
Q3
$2.89M Sell
6,549
-14,168
-68% -$6.26M 0.06% 256
2020
Q2
$7.51M Buy
20,717
+12,301
+146% +$4.46M 0.19% 87
2020
Q1
$2.39M Buy
8,416
+889
+12% +$252K 0.13% 130
2019
Q4
$2.45M Buy
7,527
+5,914
+367% +$1.92M 0.05% 250
2019
Q3
$470K Sell
1,613
-31,329
-95% -$9.13M 0.02% 657
2019
Q2
$9.67M Buy
32,942
+20,753
+170% +$6.09M 0.38% 29
2019
Q1
$3.34M Buy
12,189
+11,267
+1,222% +$3.08M 0.25% 64
2018
Q4
$206K Buy
+922
New +$206K 0.01% 258